The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

CN Kotton, D Kumar, AM Caliendo, S Huprikar… - …, 2018 - journals.lww.com
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation

AP Limaye, TM Babu, M Boeckh - Clinical Microbiology Reviews, 2020 - Am Soc Microbiol
Hosts with compromised or naive immune systems, such as individuals living with HIV/AIDS,
transplant recipients, and fetuses, are at the highest risk for complications from …

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

RR Razonable, A Humar - Clinical transplantation, 2019 - Wiley Online Library
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant/refractory disease

CN Kotton, N Kamar - Infectious Diseases and Therapy, 2023 - Springer
Cytomegalovirus (CMV) infection can have both direct and indirect effects after solid-organ
transplantation, with a significant impact on transplant outcomes. Prevention strategies …

[HTML][HTML] Cytomegalovirus infection after liver transplantation

BC Lizaola-Mayo, EA Rodriguez - World Journal of Transplantation, 2020 - ncbi.nlm.nih.gov
Human cytomegalovirus (CMV) represents the most common opportunistic infection in liver
transplant recipients. CMV infections in post liver transplant patients cause significant …

Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update

K Prakash, A Chandorkar, KK Saharia - Diagnostics, 2021 - mdpi.com
Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …

Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells

T Ivana, P Robert, S Pavel, T Lenka, K Irena - Transplant Immunology, 2022 - Elsevier
Herpesviruses can either cause primary infection or may get reactivated after both
hematopoietic cell and solid organ transplantations. In general, viral infections increase post …

Screening of novel drugs for inhibiting hepatitis E virus replication

T Nishiyama, T Kobayashi, S Jirintai, I Kii… - Journal of virological …, 2019 - Elsevier
Hepatitis E, which is caused by hepatitis E virus (HEV), is generally a self-limiting, acute, and
rarely fatal disease. It is sometimes fulminant and lethal, especially during pregnancy …

Intestinal transplantation: a review

L Loo, G Vrakas, S Reddy, P Allan - Current opinion in …, 2017 - journals.lww.com
With advancements in immunosuppressive drugs, induction regimens, standardization of
surgical techniques and improved postoperative care, survival is increasing. In due course, it …

Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir

J Piret, G Boivin - Infectious Disease Reports, 2024 - mdpi.com
Cytomegalovirus (CMV) infections may increase morbidity and mortality in
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …